1.
Gottlieb AB, Elewski BE, Okun MM, Bagel J, Poulin Y, Gu Y, Geng Z, Williams DA, Valdecantos WC. Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. J of Skin [Internet]. 2017Oct.27 [cited 2022Jul.5];1(3.1):s97. Available from: https://www.jofskin.org/index.php/skin/article/view/75